Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuxiang Li

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Emerging Microbes & Infections|August 5, 2018
Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in miceJing Xu, Shuxiang Li, Xinyi Wang, et al.
Cell Communication and Signaling : CCS|September 11, 2024
Bivalent chromatin accommodates survivin and BRG1/SWI complex to activate DNA damage response in CD4<sup>+</sup> cellsVenkataragavan Chandrasekaran, Karin M E Andersson, Malin Erlandsson, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)Hong You, Weijia Duan, Shuxiang Li, et al.
Journal of Gastroenterology|January 13, 2026
Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitisLi Shen, Tingting Lv, Shuxiang Li, et al.
Hepatology International|January 14, 2022
Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitisSha Chen, Tingting Lv, Guangyong Sun, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2026
Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patientsBuer Li, Shuxiang Li, Sha Chen, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2026
Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patientsBuer Li, Shuxiang Li, Sha Chen, et al.
Therapeutic Advances in Gastroenterology|January 22, 2024
Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomenaMengqi Li, Sha Chen, Shuxiang Li, et al.
Journal of Gastroenterology and Hepatology|October 27, 2018
Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from ChinaSha Chen, Weijia Duan, Min Li, et al.
Structure (London, England : 1993)|March 26, 2021
Na<sub>V</sub>1.2 EFL domain allosterically enhances Ca<sup>2+</sup> binding to sites I and II of WT and pathogenic calmodulin mutants bound to the channel CTDRyan Mahling, Liam Hovey, Holly M Isbell, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Emerging Microbes & Infections|August 5, 2018
Systemic and mucosal humoral immune responses induced by the JY-adjuvanted nasal spray H7N9 vaccine in miceJing Xu, Shuxiang Li, Xinyi Wang, et al.
Cell Communication and Signaling : CCS|September 11, 2024
Bivalent chromatin accommodates survivin and BRG1/SWI complex to activate DNA damage response in CD4<sup>+</sup> cellsVenkataragavan Chandrasekaran, Karin M E Andersson, Malin Erlandsson, et al.
Journal of Clinical and Translational Hepatology|March 27, 2023
Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)Hong You, Weijia Duan, Shuxiang Li, et al.
Journal of Gastroenterology|January 13, 2026
Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitisLi Shen, Tingting Lv, Shuxiang Li, et al.
Hepatology International|January 14, 2022
Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitisSha Chen, Tingting Lv, Guangyong Sun, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2026
Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patientsBuer Li, Shuxiang Li, Sha Chen, et al.
European Journal of Gastroenterology & Hepatology|May 29, 2026
Fenofibrate add-on therapy improves transplant-free survival in primary biliary cholangitis patientsBuer Li, Shuxiang Li, Sha Chen, et al.
Therapeutic Advances in Gastroenterology|January 22, 2024
Add-on immunosuppressive therapy may benefit selected patients with primary biliary cholangitis and autoimmune phenomenaMengqi Li, Sha Chen, Shuxiang Li, et al.
Journal of Gastroenterology and Hepatology|October 27, 2018
Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from ChinaSha Chen, Weijia Duan, Min Li, et al.
Structure (London, England : 1993)|March 26, 2021
Na<sub>V</sub>1.2 EFL domain allosterically enhances Ca<sup>2+</sup> binding to sites I and II of WT and pathogenic calmodulin mutants bound to the channel CTDRyan Mahling, Liam Hovey, Holly M Isbell, et al.
Pageof 10